Giuseppe Procopio
Impact in
- Oncology top 0.5%
- Lung Cancer Research Studies
- Cancer Immunotherapy and Biomarkers
- Pulmonary and Respiratory Medicine top 0.5%
- Renal cell carcinoma treatment
- Prostate Cancer Treatment and Research
Papers in
-
- Renal cell carcinoma treatment 185
- Prostate Cancer Treatment and Research 84
- Cancer Research 112
- Cancer Genomics and Diagnostics 93
- Co-authors
- Elena VerzoniEmilio BajettaFilippo de BraudSilke GillessenKarim FizaziAntonia MartinettiPiet OstChris Parker
- Journals
- Journal of Clinical Oncology (87 papers)Annals of Oncology (48 papers)Clinical Genitourinary Cancer (14 papers)Expert Review of Anticancer Therapy (10 papers)European Journal of Cancer (8 papers)
- Partner nations
- ItalyUnited StatesFrance
In The Last Decade
Giuseppe Procopio
336 papers receiving 5.1k citations
Hit Papers
Peers
Comparison fields: 5 of 109
- Oncology 2.7k
- Pulmonary and Respiratory Medicine 3.1k
- Cancer Research 1.2k
- Neurology 620
- Epidemiology 986
Countries citing papers authored by Giuseppe Procopio
This map shows the geographic impact of Giuseppe Procopio's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Giuseppe Procopio with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Giuseppe Procopio more than expected).
Fields of papers citing papers by Giuseppe Procopio
This network shows the impact of papers produced by Giuseppe Procopio. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Giuseppe Procopio. The network helps show where Giuseppe Procopio may publish in the future.
Co-authorship network
The 25 scholars most cited alongside Giuseppe Procopio, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
| # | Work | ||
|---|---|---|---|
| 1 | 2025 | 0 | |
| 2 | 2025 | 1 | |
| 3 | 2025 | 1 | |
| 4 | 2024 | 1 | |
| 5 | 2024 | 1 | |
| 6 | 2023 | 7 | |
| 7 | 2023 | 2 | |
| 8 | 2022 | 2 | |
| 9 | 2021 | 3 | |
| 10 | 2021 | 2 | |
| 11 | 2021 | 2 | |
| 12 | 2021 | 7 | |
| 13 | 2021 | 5 | |
| 14 | 2020 | 2 | |
| 15 | 2020 | 6 | |
| 16 | 2020 | 2 | |
| 17 | 2019 | 21 | |
| 18 | 2017 | 3 | |
| 19 | 2014 | 3 | |
| 20 | 2014 | 8 |
About Giuseppe Procopio
Giuseppe Procopio is a scholar working on Pulmonary and Respiratory Medicine, Cancer Research, Oncology, Radiology, Nuclear Medicine and Imaging and Economics and Econometrics, having authored 360 papers that have together received 5.2k indexed citations. Recurring topics across this work include Renal cell carcinoma treatment (185 papers), Cancer Genomics and Diagnostics (93 papers), Prostate Cancer Treatment and Research (84 papers), Renal and related cancers (73 papers), Cancer Immunotherapy and Biomarkers (58 papers), Radiopharmaceutical Chemistry and Applications (52 papers), Economic and Financial Impacts of Cancer (37 papers) and Neuroendocrine Tumor Research Advances (30 papers). The work is most often cited by research in Oncology (2.7k citations), Pulmonary and Respiratory Medicine (3.1k citations), Cancer Research (1.2k citations), Neurology (620 citations) and Epidemiology (986 citations). Giuseppe Procopio has collaborated with scholars based in Italy, United States and France. Frequent co-authors include Elena Verzoni, Emilio Bajetta, Filippo de Braud, Silke Gillessen, Karim Fizazi, Antonia Martinetti, Piet Ost, Chris Parker, Elena Castro and Axel Heidenreich. Their work appears in journals such as Journal of Clinical Oncology, Annals of Oncology, Clinical Genitourinary Cancer, Expert Review of Anticancer Therapy and European Journal of Cancer.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.